Phathom Pharmaceuticals (PHAT) Other Non Operating Income: 2022-2025
Historic Other Non Operating Income for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to -$7,000.
- Phathom Pharmaceuticals' Other Non Operating Income rose 12.50% to -$7,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$135,000, marking a year-over-year decrease of 90.14%. This contributed to the annual value of -$8,000 for FY2024, which is 95.74% up from last year.
- Per Phathom Pharmaceuticals' latest filing, its Other Non Operating Income stood at -$7,000 for Q3 2025, which was up 95.48% from -$155,000 recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Other Non Operating Income registered a high of $49,000 during Q4 2024, and its lowest value of -$197,000 during Q3 2023.
- For the 3-year period, Phathom Pharmaceuticals' Other Non Operating Income averaged around -$34,545, with its median value being -$8,000 (2024).
- Its Other Non Operating Income has fluctuated over the past 5 years, first surged by 450.00% in 2024, then plummeted by 2,483.33% in 2025.
- Over the past 4 years, Phathom Pharmaceuticals' Other Non Operating Income (Quarterly) stood at -$90,000 in 2022, then surged by 84.44% to -$14,000 in 2023, then skyrocketed by 450.00% to $49,000 in 2024, then grew by 12.50% to -$7,000 in 2025.
- Its last three reported values are -$7,000 in Q3 2025, -$155,000 for Q2 2025, and -$22,000 during Q1 2025.